SIO GENE THERAPIES INC (SIOX) Stock Price & Overview
NASDAQ:SIOX • US8293991043
Current stock price
The current stock price of SIOX is 0.415 USD. Today SIOX is up by 2.09%. In the past month the price increased by 1.47%. In the past year, price decreased by -40.98%.
SIOX Key Statistics
- Market Cap
- 30.7M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.68
- Dividend Yield
- N/A
SIOX Stock Performance
SIOX Stock Chart
SIOX Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to SIOX. When comparing the yearly performance of all stocks, SIOX is a bad performer in the overall market: 81.9% of all stocks are doing better.
SIOX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SIOX. While SIOX seems to be doing ok healthwise, there are quite some concerns on its profitability.
SIOX Earnings
SIOX Forecast & Estimates
7 analysts have analysed SIOX and the average price target is 5.1 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.415.
SIOX Groups
Sector & Classification
SIOX Financial Highlights
Over the last trailing twelve months SIOX reported a non-GAAP Earnings per Share(EPS) of -0.68. The EPS increased by 2.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
SIOX Ownership
SIOX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.12 | 388.573B | ||
| AMGN | AMGEN INC | 15.42 | 194.674B | ||
| GILD | GILEAD SCIENCES INC | 16.03 | 179.261B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.41 | 117.486B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.01 | 80.247B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.51 | 42.494B | ||
| INSM | INSMED INC | N/A | 31.024B | ||
| NTRA | NATERA INC | N/A | 28.116B | ||
| BIIB | BIOGEN INC | 11.33 | 27.193B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.75 | 23.669B | ||
| MRNA | MODERNA INC | N/A | 21.299B | ||
| EXAS | EXACT SCIENCES CORP | 341.74 | 19.841B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.645B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SIOX
Company Profile
Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2015-06-11. The firm is focused on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease. The firm is primarily focused on pre-clinical research and development initiatives in gene therapy.
Company Info
IPO: 2015-06-11
SIO GENE THERAPIES INC
1501 Broadway, 12Th Floor
New York City NEW YORK 10036 US
CEO: Pavan Cheruvu
Employees: 12
Phone: 18777464891.0
SIO GENE THERAPIES INC / SIOX FAQ
What does SIO GENE THERAPIES INC do?
Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2015-06-11. The firm is focused on pushing the boundaries of gene therapy to develop treatments for debilitating rare neurodegenerative diseases, including GM1 gangliosidosis and Tay-Sachs/Sandhoff disease. The firm is primarily focused on pre-clinical research and development initiatives in gene therapy.
What is the current price of SIOX stock?
The current stock price of SIOX is 0.415 USD. The price increased by 2.09% in the last trading session.
Does SIO GENE THERAPIES INC pay dividends?
SIOX does not pay a dividend.
What is the ChartMill rating of SIO GENE THERAPIES INC stock?
SIOX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Should I buy SIOX stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SIOX.
What is SIO GENE THERAPIES INC worth?
SIO GENE THERAPIES INC (SIOX) has a market capitalization of 30.70M USD. This makes SIOX a Nano Cap stock.
What is the ownership structure of SIO GENE THERAPIES INC (SIOX)?
You can find the ownership structure of SIO GENE THERAPIES INC (SIOX) on the Ownership tab.